Global Network · Asia-Pacific
Tokyo
Tokyo covers relationships that take years to open. Four people at Otemachi Court hold six counterparty relationships with Japanese manufacturers, monitor the three positions the group holds in them and account for US$9 million of the client portfolio. The entity is registered for investment advisory and agency business and executes nothing on its own account.
A separate research company contracts the licensing and co-development work through which specialty-materials relationships usually begin, because a Japanese counterparty will often agree to a joint programme before it will agree to a sale. Sumida Information Systems supplies the supply-chain data the office uses, held under the provenance requirements of the Ethical Technology Charter.
Yumiko Sandoval-Reyes, the independent director who spent her career in pharmaceutical regulatory affairs, is based in the city and joined the Board in the year the office opened. The 2027 Asia-Pacific phase adds research and relationship staff here, on the argument that Japanese coverage improves with time served rather than with headcount alone.
Functions
- Pharmaceutical and specialty-materials relationships in Japan
- Monitoring of the Japanese portfolio positions
- Licensing and co-development contracting
- Regional research on specialty-materials supply
Office lead
Haruki Nishimura-Castellanos, Head of Office, Tokyo